Luigi Mangione may face his federal death penalty trial for the alleged killing of UnitedHealthcare CEO Brian Thompson before the year’s end, according to a judge’s statement on Friday. The defense has requested the government to exclude the death penalty option from the case.
U.S. District Judge Margaret Garnett mentioned the trial could commence in December or potentially in January 2027, as suggested by federal prosecutors, in case the death penalty remains applicable. If not, the trial might be set for October. Garnett anticipates jury selection to start around September 8. There is no set trial date for Mangione’s state murder case yet, as prosecutors previously indicated they expected the state trial to precede the federal one.
Garnett plans to finalize a schedule after reviewing her calendar and notes from discussions with the court’s jury coordinator. The judge will also rule later on defense motions to prevent the prosecution from pursuing the death penalty, dismiss certain charges, and exclude specific evidence. Another pretrial conference is scheduled for January 30.
Mangione’s legal team argues that authorities unfairly influenced the case by sensationalizing his December 2024 arrest and publicly expressing their desire for his execution even before formal indictment. They are also seeking the dismissal of two charges, including the murder by firearm charge that allows the government to seek the death penalty, citing legal flaws.
Federal prosecutors refute the defense’s claims, asserting that the murder charge is legally sound and that intense pretrial publicity does not constitute a constitutional crisis. They propose that potential juror biases can be mitigated through thorough questioning during the selection process.
Mangione has pleaded not guilty to both federal and state murder charges, each carrying the potential for life imprisonment.
In another development, supporters gathered at the courthouse for Mangione’s recent appearance in Manhattan federal court. The hearing marked his first court appearance since his arraignment in April 25. Supporters, critical of the health insurance industry, rallied outside the courthouse with signs advocating for Mangione’s freedom and opposing the death penalty.
During the proceedings, Mangione, dressed in a beige jail uniform, remained silent, engaging with his attorneys and reviewing documents. Besides the death penalty issue, Judge Garnett is considering a defense motion to suppress certain items seized during Mangione’s arrest, including a gun allegedly linked to Thompson’s murder and a notebook detailing plans to harm a health insurance executive.
Prosecutors argue that the search of the backpack containing the items was lawful, as police were ensuring public safety. They contend that the evidence would have been discovered eventually, even without the search.
Thompson, aged 50, was fatally shot on December 4, 2024, en route to a Manhattan hotel for a corporate event. Mangione, 27, was apprehended five days later in Pennsylvania. He has already succeeded in dismissing state terrorism charges against him earlier.
Last year, U.S. Attorney General Pam Bondi authorized federal prosecutors to pursue the death penalty, justifying it as appropriate for what she labeled a “premeditated, cold-blooded assassination.” Mangione’s defense team argues that Bondi’s decision was politically motivated, casting doubt on the fairness of the indictment process.
The ongoing legal proceedings have garnered attention and raised concerns, with the next pretrial conference and ruling dates pending.
